Drug intelligence / Profile preview

isotonic short-peptide enteral nutrition emulsion

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Peptides
Administration
Oral, Tube Feeding (nasogastric/nasojejunal/gastrostomy/jejunostomy)
01

Overview

Isotonic short-peptide enteral nutrition emulsion is a specialized medical nutrition product designed for patients with impaired digestive and/or absorptive function who cannot tolerate whole protein or large-molecule nutrient formulas. The formulation uses pre-digested peptides (short peptides) as the primary nitrogen source, along with carbohydrates and medium-chain triglycerides (MCTs), to enhance absorption and reduce gastrointestinal burden. It is isotonic (approximately 300 mOsm/L), which improves gastrointestinal tolerance compared to hypertonic formulations and reduces the risk of diarrhea and gastric retention. This product is indicated for conditions such as short bowel syndrome, pancreatic insufficiency, chronic inflammatory bowel disease, chemotherapy/radiation-induced enteritis, critically ill patients, or those transitioning from parenteral to enteral nutrition. It can be used as complete or supplemental enteral nutrition via oral intake or tube feeding[1][2][3][6].

Brand names
瑞易西
Other names
等渗短肽肠内营养乳剂SP型肠内营养乳剂Survimed OPD
02

Targets

PepT1/PepT2 (Peptide transporters 1/2)

Beyond the preview

Go deeper on isotonic short-peptide enteral nutrition emulsion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on isotonic short-peptide enteral nutrition emulsion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call